524703 — Sandu Pharmaceuticals Share Price
0.000.00%
Last trade - 00:00- IN₹592.22m
- IN₹549.88m
- IN₹653.49m
- 66
- 34
- 45
- 45
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.47 | ||
| Price to Tang. Book | 1.47 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.88 | ||
| EV to EBITDA | 25.3 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3.97% | ||
| Return on Equity | 2.9% | ||
| Operating Margin | 2.45% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 494.25 | 483.67 | 587.55 | 655 | 653.49 | n/a | n/a | 5.86% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +27.8 | +7.65 | +51.14 | +21.27 | -13.76 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Sandu Pharmaceuticals Limited is an India-based company, which is mainly engaged in the business of manufacturing and trading of ayurvedic medicines under the brand name, SANDU. The Company's product category includes digestive health, immunity, muscle and bone health, respiratory health, wellness, and others. Its digestive health products focus on constipation, hyperacidity, indigestion and flatulence, and loose motions, among others. Its wellness products cover female wellness, male wellness and mother and child. Its respiratory health products focus on respiratory health, asthma, and cold and cough. Its ayurveda category includes herbs, panchakarma, dincharya, rutucharya, ahar vihar, arogyadarshika, prakruti and yoga. The Company also offers products, such as an immunity kit and a power herbs range. Its products are manufactured using in-house know-how supplied by Sandu Brothers Private Limited. The Company's products are sold through e-commerce marketplaces.
Directors
- Last Annual
- March 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- November 15th, 1985
- Public Since
- September 26th, 1994
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 9,660,990
- Address
- D-124, MUMBAI, 400706
- Web
- https://sandu.in/
- Phone
- +91 7777041566
- Auditors
- Dileep & Prithvi
Upcoming Events for 524703
Q1 2025 Sandu Pharmaceuticals Ltd Earnings Release
Similar to 524703
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
Ambalal Sarabhai Enterprises
Bombay Stock Exchange
FAQ
What is the Sandu Pharmaceuticals share price?
As of Today at 19:18 UTC, shares in Sandu Pharmaceuticals are trading at IN₹61.30. This share price information is delayed by 15 minutes.
How has the Sandu Pharmaceuticals share price performed this year?
Shares in Sandu Pharmaceuticals last closed at IN₹61.30 and the price had moved by +7.58% over the past 365 days. In terms of relative price strength the Sandu Pharmaceuticals share price has underperformed the S&P BSE 100 Index by -17.36% over the past year.
What are the analyst and broker recommendations for Sandu Pharmaceuticals?
There is no consensus recommendation for this security.
What is the Sandu Pharmaceuticals dividend yield?
The Sandu Pharmaceuticals dividend yield is 1.22% based on the trailing twelve month period.
Does Sandu Pharmaceuticals pay a dividend?
Last year, Sandu Pharmaceuticals paid a total dividend of IN₹0.75, and it currently has a trailing dividend yield of 1.22%. We do not have any data on when Sandu Pharmaceuticals is to next pay dividends.
When does Sandu Pharmaceuticals next pay dividends?
We do not have data on when Sandu Pharmaceuticals is to next pay dividends. The historic dividend yield on Sandu Pharmaceuticals shares is currently 1.22%.
How do I buy Sandu Pharmaceuticals shares?
To buy shares in Sandu Pharmaceuticals you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Sandu Pharmaceuticals?
As of the previous close price of IN₹61.30, shares in Sandu Pharmaceuticals had a market capitalisation of IN₹592.22m.
Where are Sandu Pharmaceuticals shares listed?
Here are the trading details for Sandu Pharmaceuticals:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 524703
What kind of share is Sandu Pharmaceuticals?
Based on an overall assessment of its quality, value and momentum Sandu Pharmaceuticals is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Sandu Pharmaceuticals share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Sandu Pharmaceuticals share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sandu Pharmaceuticals. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -19.81%.
As of the last closing price of IN₹61.30, shares in Sandu Pharmaceuticals were trading -5.83% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Sandu Pharmaceuticals PE Ratio?
The Sandu Pharmaceuticals PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹61.30.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Sandu Pharmaceuticals?
We do not have data on Sandu Pharmaceuticals' directors